Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention

Journal of Thrombosis and Thrombolysis

Volumn 35, Issue 1, 2013, Pages 57-64

  Fatemi, Omid ^a   Paranilam, Jaya ^b   Rainow, Alex ^c   Kennedy, Kevin ^d   Choi, Jason ^e   Cutlip, Donald ^e,f   Pencina, Michael ^f,g   Berger, Peter B ^h   Cohen, David J ^d   Kleiman, Neal S ^b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^g BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^h GEISINGER MEDICAL CENTER   (United States)

Author keywords

EVENT; PCI; RDW; Stent

Indexed keywords

CREATININE; FIBRINOGEN RECEPTOR ANTAGONIST; HEMOGLOBIN;

ADULT; AGED; ARTICLE; BARE METAL STENT; BLOOD CELL COUNT; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; DRUG ELUTING STENT; ERYTHROCYTE PARAMETERS; FEMALE; GENDER; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RED CELL DISTRIBUTION WIDTH; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; DRUG-ELUTING STENTS; ERYTHROCYTE COUNT; ERYTHROCYTES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEX FACTORS;

EID: 84871811640     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0767-x     Document Type: Article

References (30)

1. Zalawadiya SK, Veeranna V, Niraj A, Pradhan J, Afonso L (2010) Red cell distribution width and risk of coronary heart disease events. Am J Cardiol 106(7):988-993
2. Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM (2009) Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med 169(5):515-523
3. Perlstein TS, Weuve J, Pfeffer MA, Beckman JA (2009) Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med 169(6):588-594
4. Poludasu S, Marmur JD, Weedon J, Khan W, Cavusoglu E (2009) Red cell distribution width (RDW) as a predictor of long-term mortality in patients undergoing percutaneous coronary intervention. Thromb Haemost 102(3):581-587
5. Jacob S, Cohen DJ, Massaro J, Niemyski P, Maresh K, Kleiman N (2005) Design of a registry to characterize "real-world" outcomes of percutaneous coronary revascularization in the drug-eluting stent era. Am Heart J 150(5):887-892
6. Win HK, Caldera AE, Maresh K et al (2007) Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 297(18):2001-2009
7. Cuzick J (1985) A Wilcoxon-type test for trend. Stat Med 4(1):87-90
8. Pencina MJ, D'Agostino RB, D'Agostino RB Sr, Vasan RS Jr (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27(2):157-172 discussion 207-12
9. Pencina MJ, D'Agostino RB Sr, Steyerberg EW (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30(1):11-21
10. Pencina MJ, D'Agostino RB Sr, Demler OV (2012) Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models. Stat Med 31:101-113
11. Allen LA, Felker GM, Mehra MR et al (2010) Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail 16(3):230-238
12. Felker GM, Allen LA, Pocock SJ et al (2007) Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke databank. J Am Coll Cardiol 50(1):40-47
13. van Kimmenade RR, Mohammed AA, Uthamalingam S, van der Meer P, Felker GM, Januzzi JL Jr (2010) Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail 12(2):129-136
14. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M (2008) Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 117(2):163-168
15. Ani C, Ovbiagele B (2009) Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci 277(1-2):103-108
16. Cavusoglu E, Chopra V, Gupta A et al (2010) Relation between red blood cell distribution width (RDW) and all-cause mortality at 2 years in an unselected population referred for coronary angiography. Int J Cardiol 141(2):141-146
17. Dabbah S, Hammerman H, Markiewicz W, Aronson D (2010) Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol 105(3):312-317
18. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC (2009) Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 133(4):628-632
19. Forhecz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohaszka Z, Janoskuti L (2009) Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J 158(4):659-666
20. Ghaffari S (2008) Oxidative stress in the regulation of normal and neoplastic hematopoiesis. Antioxid Redox Signal 10(11):1923-1940
21. Wen Y (2010) High red blood cell distribution width is closely associated with risk of carotid artery atherosclerosis in patients with hypertension. Exp Clin Cardiol 15(3):37-40
22. de Sauvage FJ, Hass PE, Spencer SD et al (1994) Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369(6481):533-538
23. Stohlawetz PJ, Dzirlo L, Hergovich N et al (2000) Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood 95(9):2983-2989
24. Guthikonda S, Alviar CL, Vaduganathan M et al (2008) Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 52(9):743-749
25. Arbustini E (2007) Total erythrocyte membrane cholesterol: an innocent new marker or an active player in acute coronary syndromes? J Am Coll Cardiol 49(21):2090-2092
26. Kolodgie FD, Gold HK, Burke AP et al (2003) Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349(24):2316-2325
27. Pasterkamp G, Virmani R (2002) The erythrocyte: a new player in atheromatous core formation. Heart 88(2):115-116
28. Sun Q, Ma J, Campos H et al (2007) A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 115(14):1858-1865
29. Turitto VT, Weiss HJ (1980) Red blood cells: their dual role in thrombus formation. Science 207(4430):541-543
30. Tziakas DN, Kaski JC, Chalikias GK et al (2007) Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability? J Am Coll Cardiol 49(21):2081-2089